Latest / Health and life sciences
Isomorphic Labs signs AI drug-design deals with Eli Lilly and Novartis worth nearly $3bn
See how this story connectsIsomorphic Labs announced AI drug-discovery research collaborations with Eli Lilly and Novartis on 7 January 2024. Lilly paid $45m upfront and Novartis $37.5m, and the two deals together could pay Isomorphic nearly $3bn in upfront and milestone payments, excluding royalties.
Why it matters
Two large drugmakers put $82.5m upfront into AI-led drug design at one company, with nearly $3bn more possible if programmes reach their milestones.
- When
- 7 Jan 2024
- ID
WTA-N-2024-0001- Where
- United Kingdom, United States, Switzerland
- Who
- Isomorphic Labs, Eli Lilly, Novartis
Summary by wheresthe.ai, from Isomorphic Labs. Checked against the source on 9 Oct 2026.
Source copy: download the page as saved on 18 Oct 2026 (PDF). Also held by the Internet Archive.
Cite this story
WTA-N-2024-0001: “Isomorphic Labs signs AI drug-design deals with Eli Lilly and Novartis worth nearly $3bn.” wheresthe.ai, 7 Jan 2024. https://wheresthe.ai/d/gb-isomorphic-labs-lilly-novartis-deals-2024-01/ (source: Isomorphic Labs).
Spotted an error? Email [email protected].